Jiudian Pharmaceuticals (300705.SZ) has been authorized to conduct clinical trials for two drugs.

Zhixin finance and economics APP news, Jidian Pharmaceuticals (300705.SZ) announced that the company recently received the "Notice of Approval for Clinical Trial of Medicines" issued by the National Medical Products Administration. After completing related preparations, the company will conduct clinical trial research. The approved clinical trials include: JIZM01 for clinical trials of closed soft tissue contusions and joint sprains, and JIZM02 for clinical trials of shoulder periarthritis.